Durham, NC, United States of America

Joel P Cooper

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Smithkline Beecham Corporation. Active years: 2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joel P Cooper. Retrieved from https://idiyas.com/inventor/joel-p-cooper-04o75u1b

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Contributions of Inventor Joel P. Cooper

Introduction

Joel P. Cooper is a notable inventor based in Durham, North Carolina, recognized for his groundbreaking work in the field of pharmacology. With a significant patent to his name, his contributions continue to influence the medical community and pharmaceutical advancements.

Latest Patents

Cooper holds a patent for "Pyrimidinones as melanin concentrating hormone receptor 1." This patent encompasses a compound of formula (Ia), which includes a pharmaceutically acceptable salt or solvate. The patent details formulations, processes of preparation, and methods of administering this compound to mammals, showcasing his innovative approach to enhancing medical treatments.

Career Highlights

Joel P. Cooper has established himself as an essential figure at SmithKline Beecham Corporation, where he plays a critical role in research and development. His work focuses on pharmacological innovations that aim to improve patient outcomes and therapeutic options.

Collaborations

Throughout his career, Cooper has collaborated with esteemed colleagues, including Andrew J. Carpenter and Anthony Louis Handlon. These partnerships have fostered a collaborative environment that enhances scientific research and development, leading to significant advancements in their respective areas of expertise.

Conclusion

In conclusion, Joel P. Cooper’s contributions through his patent and collaborative efforts reflect his commitment to innovation in pharmacology. His work at SmithKline Beecham Corporation exemplifies how dedicated inventors can shape the future of healthcare and improve therapeutic strategies for various health conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…